|
Volumn 40, Issue 4, 2015, Pages 260-262
|
States try to control medicaid pharmaceutical costs: Numerous, diverse cost pressures force myriad reform efforts
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DASABUVIR;
IVACAFTOR;
LEDIPASVIR PLUS SOFOSBUVIR;
OMBITASVIR;
PARITAPREVIR;
RITONAVIR;
SIMEPREVIR;
SOFOSBUVIR;
BUDGET;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
CYSTIC FIBROSIS;
DRUG COST;
GOVERNMENT;
HEALTH CARE PLANNING;
HEPATITIS C;
HOSPITAL COST;
LAW;
LOWEST INCOME GROUP;
MEDICAID;
NOTE;
OUTPATIENT CARE;
PRESCRIPTION;
|
EID: 84926308449
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (7)
|
References (5)
|